Meyaard Daniel V 4
4 · IDEXX LABORATORIES INC /DE · Filed Feb 16, 2012
Insider Transaction Report
Form 4
Meyaard Daniel V
Corporate Vice President
Transactions
- Award
Restricted Stock Unit
2012-02-14+715→ 3,949 total→ Common Stock (715 underlying) - Exercise/Conversion
Restricted Stock Unit
2012-02-14−162→ 3,787 total→ Common Stock (162 underlying) - Award
Non-Qualified Stock Option (right to buy)
2012-02-14+5,971→ 5,971 totalExercise: $87.42Exp: 2019-02-13→ Common Stock (5,971 underlying) - Award
Incentive Stock Option (right to buy)
2012-02-14+1,143→ 1,143 totalExercise: $87.42Exp: 2019-02-13→ Common Stock (1,143 underlying) - Exercise/Conversion
Common Stock
2012-02-14+162→ 3,082 total
Footnotes (5)
- [F1]Includes 72 shares, 63 shares, 66 shares and 59 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 09/30/2010, 12/31/2010, 09/30/2011 and 12/30/2011, respectively.
- [F2]Grant of options to buy shares of common stock becomes exercisable as to 1,423 shares on 02/14/2013, 02/14/2014, 02/14/2015 and 02/14/2016, and the remaining 279 shares on 02/14/2017.
- [F3]Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2017) of the grant.
- [F4]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
- [F5]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.